Lymphangioleiomyomatosis (LAM)

Source: Breathe 2017; 13: 64-71

Journal Issue: March

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lymphangioleiomyomatosis (LAM). Breathe 2017; 13: 64-71

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Lymphangioleiomyomatosis Source: Eur Respir J 2006; 28: 1284 Year: 2006
Lymphangioleiomyomatosis Source: Eur Respir Mon; 2009: 46: 176–207 Year: 2009
Lymphangioleiomyomatosis Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008
LAM: lymphangioleiomyomatosis Source: Breathe 2014; 10:331-332 Year: 2014
Lymphangioleiomyomatosis (LAM) initially presented as retroperitoneal tumour. Two case reports Source: Eur Respir J 2005; 26: Suppl. 49, 83s Year: 2005
Lymphangioleiomyomatosis – an analysis of 4 cases Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007
Is pulmonary rehabilitation (PR) an effective therapy in lymphangioleiomyomatosis (LAM)? Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Lymphangioleiomyomatosis: what do we know and what are we looking for? Source: Eur Respir Rev 2011; 20: 34-44 Year: 2011
Lymphangioleiomyomatosis: characteristics of 96 patients in China Source: Annual Congress 2008 - Rare clinical cases Year: 2008
Lymphangioleiomyomatosis: a clinical review Source: Breathe, 16 (2) 200007; 10.1183/20734735.0007-2020 Year: 2020
Experience with lung transplantation in lymphangioleiomyomatosis (LAM) in our center Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008
Serial CT density in lymphangioleiomyomatosis (LAM) Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010
Differences in pulmonary function tests (PFTs) in patients with pulmonary lymphangioleiomyomatosis (LAM) and multiple benign pulmonary leiomyomatosis (MPL) Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004
Ten-years follow-up of slowly progressive pulmonary lymphangioleiomyomatosis (PLAM) Source: Eur Respir J 2001; 18: Suppl. 33, 219s Year: 2001
Case report: Hermansky-Pudlak syndrome (HPS) and single lung transplantation (LUTX) Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020
Early-onset therapy with sirolimus helps to improve prognosis of patients with lymphangioleiomyomatosis (LAM) Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019
Lymphangioleiomyomatosis Source: Eur Respir J 2006; 27: 1056-1065 Year: 2006
Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort Source: ERJ Open Res, 4 (1) 00121-2017; 10.1183/23120541.00121-2017 Year: 2018
Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM) Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013